Sunshine Biopharma Inc. Shareholders' Equity
Sunshine Biopharma Inc. (SBFM) had Shareholders' Equity of $27.54 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $27.54M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $21.52M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $23.04M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $24.20M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $27.54M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $21.52M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $23.04M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $24.20M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $25.68M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $22.70M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $23.50M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $25.04M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $23.49M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $24.82M 10-Q · filed 2025-08-12 | |
| 2023-12-31 | $21.21M 10-K · filed 2026-04-03 | |
| 2023-09-30 | $21.96M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $23.11M 10-Q · filed 2024-11-05 | |
| 2023-03-31 | $19.43M 10-Q/A · filed 2024-08-20 | |
| 2022-12-31 | $21.63M 10-K · filed 2025-04-01 | |
| 2022-09-30 | $40.38M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $41.89M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $13.31M 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $211.66K 10-K · filed 2024-03-28 | |
| 2021-09-30 | -$1.17M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | -$872.71K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | -$1.08M 10-Q · filed 2022-08-03 | |
| 2020-12-31 | -$954.84K 10-K · filed 2023-04-04 | |
| 2020-09-30 | -$554.88K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$577.26K 10-Q · filed 2021-11-09 | -$610.91K 10-Q · filed 2020-08-19 |
| 2020-03-31 | -$708.61K 10-Q · filed 2021-08-09 | |
| 2019-12-31 | -$735.38K 10-K · filed 2022-03-21 | |
| 2019-09-30 | -$742.86K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$816.30K 10-Q · filed 2020-11-12 | |
| 2019-03-31 | -$211.77K 10-Q/A · filed 2020-08-31 | |
| 2018-12-31 | -$55.75K 10-K · filed 2021-03-30 | |
| 2018-09-30 | $44.66K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$276.13K 10-Q · filed 2019-11-13 | |
| 2018-03-31 | -$500.69K 10-Q · filed 2019-08-15 | |
| 2017-12-31 | -$573.36K 10-K · filed 2020-05-01 | |
| 2017-09-30 | -$353.87K 10-Q · filed 2017-11-15 | |
| 2017-06-30 | -$616.29K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | -$261.04K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | -$209.70K 10-K · filed 2019-04-12 | |
| 2016-09-30 | $322.64K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$471.37K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | -$355.39K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | -$597.04K 10-K · filed 2018-04-02 | |
| 2015-09-30 | -$332.93K 10-Q · filed 2015-11-04 | |
| 2015-06-30 | -$265.32K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$230.53K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$387.58K 10-K · filed 2017-04-17 | |
| 2014-09-30 | -$276.36K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$338.22K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$113.23K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | -$7.71K 10-K · filed 2016-03-25 | |
| 2013-09-30 | $48.08K 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $146.13K 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $236.60K 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $70.43K 10-K · filed 2015-03-11 | |
| 2012-09-30 | $253.19K 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $79.59K 10-Q · filed 2012-08-08 | |
| 2012-03-31 | $63.66K 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $103.00K 10-K · filed 2014-03-19 | |
| 2011-09-30 | $219.67K 10-Q · filed 2011-11-08 | |
| 2010-12-31 | $196.22K 10-K · filed 2014-03-19 | |
| 2009-12-31 | $97.80K 10-K · filed 2014-03-19 | |
| 2009-09-30 | $336.11K 10-K · filed 2014-03-19 | |
| 2009-08-16 | $0.00 10-K · filed 2012-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |